BACKGROUND: Helicobacter pylori may be found during upper gastrointestinal endoscopy (UGE) performed to diagnose celiac disease (CeD), inflammatory bowel disease (IBD), and eosinophilic esophagitis (EoE). We aimed to describe the frequency of H. pylori in children undergoing UGE for CeD, IBD, and EoE and the number of children receiving eradication treatment. MATERIALS AND METHODS: A retrospective multicenter study from 14 countries included pediatric patients diagnosed with CeD, IBD, and EoE between January 2019 and December 2021. DATA COLLECTED: age, gender, hematologic parameters, endoscopic, histologic, and H. pylori culture results, and information on eradication treatment. RESULTS: H. pylori was identified in 349/3890 (9%) children [167 (48%) male, median 12 years (interquartile range 8.1-14.6)]. H. pylori was present in 10% (173/1733) CeD, 8.5% (110/1292) IBD and 7.6% (66/865) EoE patients (p = NS). The prevalence differed significantly between Europe (Eastern 5.2% (28/536), Southern 3.8% (78/2032), Western 5.6% (28/513)) and the Middle East 26.6% (215/809) [odds ratio (OR) 7.96 95% confidence interval (CI) (6.31-10.1) p < 0.0001]. Eradication treatment was prescribed in 131/349 (37.5%) patients, 34.6% CeD, 35.8% IBD, and 56.1% EoE. Predictors for recommending treatment included erosions/ulcers [OR 6.45 95% CI 3.62-11.47, p < 0.0001] and nodular gastritis [OR 2.25 95% CI 1.33-3.81, p 0.003]. Treatment rates were higher in centers with a low H. pylori prevalence (<20%) [OR 3.36 95% CI 1.47-7.66 p 0.004]. CONCLUSIONS: Identifying H. pylori incidentally during UGE performed for the most common gastrointestinal diseases varies significantly among regions but not among diseases. The indications for recommending treatment are not well defined, and less than 40% of children received treatment.

• Klíčová slova
• Helicobacter pylori, children, eradication treatment, incidental diagnosis,
• MeSH
• celiakie * diagnóza   epidemiologie   MeSH
• dítě MeSH
• eozinofilní ezofagitida * epidemiologie   diagnóza   MeSH
• gastrointestinální endoskopie MeSH
• Helicobacter pylori * izolace a purifikace   MeSH
• idiopatické střevní záněty * epidemiologie   diagnóza   mikrobiologie   MeSH
• infekce vyvolané Helicobacter pylori * diagnóza   epidemiologie   farmakoterapie   MeSH
• lidé MeSH
• mladiství MeSH
• předškolní dítě MeSH
• prevalence MeSH
• retrospektivní studie MeSH
• Check Tag
• dítě MeSH
• lidé MeSH
• mladiství MeSH
• mužské pohlaví MeSH
• předškolní dítě MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• multicentrická studie MeSH
• Geografické názvy
• Evropa epidemiologie   MeSH

The prevalence of Helicobacter pylori remains high in the older population. Specific age-related peculiarities may impact the outcomes of H. pylori treatment. The aim of the study was to evaluate the diagnostics and effectiveness of H. pylori eradication between the younger and older European populations. "European Registry on H. pylori Management (Hp-EuReg)" data from 2013 to 2022 were analyzed. Patients were divided into older (≥ 60 years) and younger (18-59 years) groups. Modified intention-to-treat (mITT) and per-protocol (PP) analysis was performed. 49,461 patients included of which 14,467 (29%) were older-aged. Concomitant medications and penicillin allergy were more frequent among the older patients. Differences between younger and older populations were observed in treatment duration in first-line treatment and in proton pump inhibitors (PPIs) doses in second-line treatment. The overall incidence of adverse events was lower in the older adults group. The overall first-line treatment mITT effectiveness was 88% in younger and 90% in the older patients (p < 0.05). The overall second-line mITT treatment effectiveness was 84% in both groups. The effectiveness of the most frequent first- and second-line triple therapies was suboptimal (< 90%) in both groups. Optimal efficacy (≥ 90%) was achieved by using bismuth and non-bismuth-based quadruple therapies. In conclusion, the approach to the diagnostics and treatment of H. pylori infection did not generally differ between younger and older patients. Main differences were reported in the concurrent medications, allergy to penicillin and adverse events both in first- and second-line treatment. Optimal effectiveness rates were mostly achieved by using bismuth and non-bismuth-based quadruple therapies. No clinically relevant differences in the effectiveness between the age groups were observed.

• MeSH
• alergie * farmakoterapie   MeSH
• antibakteriální látky škodlivé účinky   MeSH
• bismut terapeutické užití   MeSH
• Helicobacter pylori * MeSH
• infekce vyvolané Helicobacter pylori * farmakoterapie   epidemiologie   MeSH
• inhibitory protonové pumpy škodlivé účinky   MeSH
• kombinovaná farmakoterapie MeSH
• lidé MeSH
• peniciliny terapeutické užití   MeSH
• senioři MeSH
• výsledek terapie MeSH
• Check Tag
• lidé MeSH
• senioři MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Názvy látek
• antibakteriální látky MeSH
• bismut MeSH
• inhibitory protonové pumpy MeSH
• peniciliny MeSH

INTRODUCTION: Helicobacter pylori (H. pylori) infection is common in developing countries such as Benin. This germ may cause the development of gastroduodenal diseases, ranging from gastritis to gastric cancer. Several studies on this bacterium carried out in Benin have used serology, anatomopathological examination of biopsies or antigen detection test on stool sample collections. The purpose of this study was to assess the prevalence of H. pylori infection and factors associated with H. pylori infection using a respiratory test. The bacterium could cause chronic inflammation of the gastric mucosa and peptic ulcer disease or, more rarely, gastric cancer or lymphoma. METHODS: we conducted a prospective, descriptive study of 150 patients who performed carbon-14 urea breath test. Only patients admitted for respiratory test and who gave their consent were included. A survey was completed by all patients during the study. Simple univariate logistic regression analysis identified factors associated with H. pylori infection at a threshold of 0.05. Multivariate analysis included in the model all variables with a p-value less than 0.20. Manual top-down procedure was used until the final model was obtained, which allowed the retention of adjusted odds ratios for factors associated. RESULTS: the average age of patients was 44.4±15.8 years, ranging from 5 to 84 years; men accounted for 54% of the study population. Of the 150 subjects, 82 (57.8%) had higher education level, compared with 8 (5.6%) who were not educated, 116 (80.6%) lived with a partner, 24 (36%) lived in a room with more than 10 people and 84 (59.6%) were christians. The main reasons why respiratory tests were performed were: poorly systematized abdominal pain (53.3%; 70/150), epigastric induced pain (35.3%; 53/150), epigastralgia (20.7%; 31/150), ulcer syndrome (16%; 24/150). Respiratory test showed that the prevalence of H. pylori in the study population was 34.7% (52/150). In multivariate analysis, the variables significantly associated with H. pylori infection were: mean age [aOR (95% CI) = 1.02; OR (95% CI) = 1.00-1.05 and p = 0.01] and prior treatment for H. pylori eradication [aOR (95% CI) = 4.79; OR (95% CI) = 1.50-13.86 and p = 0.006]. No comorbidity was associated with H. pylori infection in our series. CONCLUSION: the prevalence of H. pylori using this method was low (34.7%). It was significantly associated with mean age and prior treatment for H. pylori eradication.

INTRODUCTION: l´infection à Helicobacter pylori (H. pylori) est fréquente dans les pays en voie de développement comme le Bénin. Ce germe peut favoriser la survenue d´affections gastroduodénales, allant de la gastrite au cancer gastrique. Les différentes études réalisées au Bénin sur cette bactérie ont utilisé des méthodes telles que la sérologie, l´étude anatomo-pathologique de biopsies ou la recherche d´antigène dans les selles. La présente étude avait pour but d´évaluer la prévalence d´infection par H. pylori et les facteurs associés à cette infection en utilisant un test respiratoire. MÉTHODES: il s´agissait d´une étude prospective descriptive sur 150 patients qui ont réalisé le test respiratoire à l´urée marquée au carbone 14. Seul les patients admis pour test respiratoire et ayant donné leur consentement étaient inclus. Une fiche d´enquête a été remplie au fur et à mesure. Une analyse univariée par régression logistique simple a permis d´identifier les facteurs associés à l´infection par H. pylori à un seuil de 0,05. La stratégie d´analyse multivariée a consisté à inclure dans le model toutes les variables dont la valeur de p est inférieure à 0,20. La procédure manuelle descendante a été utilisée jusqu´à obtenir le modèle final qui a permis de retenir de facteurs associés avec des rapports de cotes ajustés. RÉSULTATS: l´âge moyen était de 44,4±15,8 ans; avec des extrêmes de 5 ans et 84 ans. Les hommes représentaient 54% de la population d´étude. Des 150 sujets, 82 (57,8%) avaient un niveau d´instruction supérieur contre 8 (5,6%) non scolarisés, 116 (80,6 %) vivaient en couple, 24 (36%) vivaient dans une chambre de plus de 10 personnes et 84 (59,6%) étaient des chrétiens. Les principaux motifs ayant conduit à la réalisation de test respiratoire étaient: douleurs abdominales mal systématisées (53,3%; 70/150), douleurs épigastriques provoquées (35,3%; 53/150), les épigastralgies (20,7%; 31/150), un syndrome ulcéreux (16%; 24/150). La prévalence d´H. pylori par test respiratoire au sein de la population étudiée était de 34,7% (52/150). En analyse multivariée, les variables significativement associées à l´infection à l´H. pylori étaient: l´âge moyen [AOR (95%IC) = 1,02; OR (95% IC) = 1,00-1,05 et p = 0,01] et la notion d´un traitement antérieur d´éradication de l´H. pylori[AOR (95%IC) = 4,79; OR (95% IC) = 1,50-13,86 et p = 0,006]. Aucune comorbidité étudiée n´était associée à l´infection par H. pylori dans notre série. CONCLUSION: la prévalence d´H. pylori trouvée par cette méthode est faible (34,7%). Elle est significativement associée à l´âge moyen et à la notion d´un traitement antérieur d´éradication de l´H. pylori.

• Klíčová slova
• Helicobacter pylori, associated factors, prevalence, respiratory test,
• MeSH
• dechové testy MeSH
• dospělí MeSH
• Helicobacter pylori * MeSH
• infekce vyvolané Helicobacter pylori * komplikace   diagnóza   epidemiologie   MeSH
• lidé středního věku MeSH
• lidé MeSH
• močovina analýza   MeSH
• prevalence MeSH
• prospektivní studie MeSH
• radioizotopy uhlíku MeSH
• Check Tag
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mužské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• Názvy látek
• Carbon-14 MeSH Prohlížeč
• močovina MeSH
• radioizotopy uhlíku MeSH

OBJECTIVE: Oropharyngeal/laryngeal carcinoma are common cancers of the upper aerodigestive system. Human papillomavirus (HPV) is described as the most frequent in the cancer of unknown primary. The presence of Helicobacter pylori (HP) in the oral cavity is discussed in some papers. THE AIM OF STUDY: To analyze the incidence of HPV and HP in oropharyngeal/laryngeal cancer persons versus persons with chronic tonsillar inflammation and healthy persons. METHODS: The samples were taken in three groups: (1) tissue of oropharynx/larynx cancer (103 specimens); (2) tissue of palatine tonsils (85 specimens); and (3) healthy control group (50 specimens). We analyzed the presence of HP (PCR) and HPV genomic DNA (Sacace HPV High-Risk Screen Real-TM Quant) in the samples. RESULTS: HP was detected in 86 samples (83.5%) and high-risk HPV in 62 samples (60.2%). We found a very high incidence of HP. In the cancer group, HP was detected in 82.5% cases and HPV positivity in 57.8%. In total, 7.2% of the cancer patients were negative for HP and HPV together. In turn, 53.6% of the cancer patients were positive for HP and HPV together. Four cases (4.2%) were positive for HPV only. VacA positivity was detected in 82 (79.6%) of the cancer cases and VacA negativity in 21 (20.4%) if the cancer cases. The incidence of HP in chronic inflammation (n = 85) was 65 cases (76.5%) and the incidence of HPV was 38 cases (44.7%). VacA positivity was detected in 59 (69.4%) of the chronic inflammation cases and VacA negativity was found in 26 (30.6%) of the chronic inflammation cases. Regarding the control group, we found HP positivity in 5 cases (11.1%) and HPV positivity in 19 cases (42.2%). There was VacA positivity in 6 cases (50.0%) of the control group. Statistically significantly lower prevalence of HP (p < 0.001) and HPV (p = 0.006) was found in the control group. CONCLUSIONS: We suggest that the palatine tonsils are colonized by HP. In our study, HP was present in oropharyngeal cancer in more cases in comparison with HPV infection. The presence of VacA from HP can have an influence on the human epithelial and immune cells' regulation ways. Our results do not support idea that the CagA-positive HP is a primary carcinogen in oropharyngeal area.

• Klíčová slova
• Helicobacter pylori, chronic inflammation, human papilloma virus, incidence, oropharynx, squamous cell carcinoma,
• MeSH
• Alphapapillomavirus * MeSH
• Helicobacter pylori * genetika   MeSH
• infekce papilomavirem * epidemiologie   MeSH
• infekce vyvolané Helicobacter pylori * epidemiologie   MeSH
• lidé MeSH
• nádory hrtanu * MeSH
• orofarynx MeSH
• Papillomaviridae genetika   MeSH
• séroskupina MeSH
• zánět MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH

BACKGROUND: Antimicrobial resistance of Helicobacter pylori can result in eradication failure. Metadata on the antimicrobial resistance of H pylori in Iran could help to formulate H pylori eradication strategies in Iran. METHODS: A systematic review was performed after searching in MEDLINE, Scopus, Embase, Web of Science, and the Cochrane Library. A meta-analysis was performed, and a comparison of the rates between children and adults; time periods (1999-2010, 2011-2016, 2017-2019); and the methods used was carried out. RESULTS: A total of 66 studies investigating 5936 H pylori isolates were analyzed. The weighted pooled resistance (WPR) rates were as follows: clarithromycin 21% (95% CI 16-26), metronidazole 62% (95% 57-67), clarithromycin in combination with metronidazole 16% (95% CI 10-23), ciprofloxacin 24% (95% CI 15-33), levofloxacin 18% (95% CI 9-30), erythromycin 29% (95% CI 12-50), furazolidone 13% (95% CI 4-27), tetracycline 8% (95% CI 5-13), and amoxicillin 15% (95% CI 9-22). During the three time periods, there was an increased resistance to amoxicillin, clarithromycin, ciprofloxacin, furazolidone, and tetracycline (P ˂ .05). Furazolidone and a clarithromycin/metronidazole combination had the higher resistance rates in children (P ˂ .05). CONCLUSION: An increasing rate of resistance to amoxicillin, clarithromycin, ciprofloxacin, furazolidone, and tetracycline in Iranian H pylori isolates was identified. In children, the resistance to furazolidone and a combination of clarithromycin and metronidazole is higher compared to adults. As a stable, high resistance to metronidazole was found in children and adults in all Iranian provinces, we suggest that metronidazole should not be included in the Iranian H pylori eradication scheme.

• Klíčová slova
• Antimicrobial resistance, Helicobacter pylori, Iran, Systematic Review and Meta-analysis,
• MeSH
• antibakteriální látky terapeutické užití   MeSH
• bakteriální léková rezistence účinky léků   MeSH
• Helicobacter pylori účinky léků   MeSH
• infekce vyvolané Helicobacter pylori * farmakoterapie   epidemiologie   MeSH
• lidé MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• metaanalýza MeSH
• systematický přehled MeSH
• Geografické názvy
• Írán epidemiologie   MeSH
• Názvy látek
• antibakteriální látky MeSH

OBJECTIVE: The epidemiology of uninvestigated dyspepsia was studied in the Czech Republic for the first time in 2001. The aim of the current multicenter prospective study was to evaluate dyspepsia using the same methods in a representative sample of general unselected population from the same geographical areas 10 years later. PARTICIPANTS AND METHODS: A total of 38 147 individuals comprised the general population for a random two-step selection process. A total of 1836 participants (863 males and 973 females; aged 5-98 years) took part in the questionnaire-based study. Helicobacter pylori status was investigated in all participants by means of C-urea breath test. RESULTS: The overall prevalence of dyspepsia was 2.6% among children and adolescents aged 5-17 years and 16.0% among adults aged 18-98 years. We did not detect any statistically significant sex differences in the prevalence of total dyspepsia or its subtypes. Overall, 2.4% of H. pylori-negative children and adolescents aged less than 18 years reported dyspepsia, and 16.8% of H. pylori-negative adults reported it. Among H. pylori-positive children and adolescents and adults, dyspepsia was present in 8.3 and 15.8%, respectively. Type A dyspepsia (as the only long-lasting symptom) was statistically significantly associated with H. pylori status among children and adolescents. Among adults aged 18 years or older, we noted a lower prevalence of dyspepsia in adults with elementary education compared with university education. Current use of antibiotics was associated with an increased prevalence of dyspepsia in adults. CONCLUSION: Despite the substantial decrease of H. pylori infection in the Czech Republic over the past 10 years, the prevalence and sociodemographic determinants of uninvestigated dyspepsia did not change significantly.

• MeSH
• antibakteriální látky terapeutické užití   MeSH
• časové faktory MeSH
• charakteristiky bydlení MeSH
• dítě MeSH
• dospělí MeSH
• dyspepsie diagnóza   epidemiologie   mikrobiologie   MeSH
• Helicobacter pylori izolace a purifikace   MeSH
• infekce vyvolané Helicobacter pylori diagnóza   epidemiologie   mikrobiologie   MeSH
• lidé středního věku MeSH
• lidé MeSH
• mladiství MeSH
• mladý dospělý MeSH
• předškolní dítě MeSH
• prevalence MeSH
• prognóza MeSH
• prospektivní studie MeSH
• rizikové faktory MeSH
• rozložení podle pohlaví MeSH
• senioři nad 80 let MeSH
• senioři MeSH
• sexuální faktory MeSH
• socioekonomické faktory * MeSH
• stupeň vzdělání MeSH
• věkové faktory MeSH
• věkové rozložení MeSH
• Check Tag
• dítě MeSH
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mladiství MeSH
• mladý dospělý MeSH
• mužské pohlaví MeSH
• předškolní dítě MeSH
• senioři nad 80 let MeSH
• senioři MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• multicentrická studie MeSH
• Geografické názvy
• Česká republika epidemiologie   MeSH
• Názvy látek
• antibakteriální látky MeSH

OBJECTIVES: Abdominal pain-related functional gastrointestinal disorders in children include functional dyspepsia, functional abdominal pain, irritable bowel syndrome, and abdominal migraine. We aimed to evaluate a possible association between functional abdominal pain disorders and Helicobacter pylori infection and faecal calprotectin level. METHODS: Prospective observational study including consecutive children with functional gastrointestinal disorders fulfilling Rome III criteria (cases) and age/sex-matched healthy controls. H pylori has been detected by biopsy-based tests and stool-antigen detection, faecal calprotectin by enzyme-linked immunosorbent assay. RESULTS: A total of 56 cases (27 with functional dyspepsia) and 56 controls were enrolled. H pylori being detected in 17 of 56 cases (30.4%) and 4 of 56 controls (7.1%, odds ratio: 5.7; 95% confidence interval [CI]: 1.8-18.2, P = 0.003). H pylori was detected significantly more frequently in cases with functional dyspepsia (14/27, 51.9% odds ratio: 14.0; 95% CI: 3.9-49.7, P = 0.00001) than in controls and not in cases with other well-recognized functional gastrointestinal complaints (3/29, 10.3%). The median faecal calprotectin level was similar in cases (7.8 μg/g, 95% CI: 7.8-8.4) including those with gastritis, and controls (9.1 μg/g, 95% CI: 7.8-11.3). Gastritis features were more frequent in H pylori-infected and noninfected cases with functional dyspepsia (27/27, 100%) than in cases with other abdominal functional complaints (15/29, 51.7%, P = 0.007). CONCLUSIONS: H pylori gastritis and noninfectious gastritis were associated with functional dyspepsia in children referred for abdominal pain-related functional gastrointestinal disorders while faecal calprotectin is not a predictor of gastritis and is similar in children with functional abdominal pain symptoms and in controls.

• MeSH
• biologické markery metabolismus   MeSH
• bolesti břicha etiologie   MeSH
• dítě MeSH
• feces chemie   MeSH
• gastritida komplikace   diagnóza   metabolismus   mikrobiologie   MeSH
• gastrointestinální nemoci komplikace   diagnóza   metabolismus   mikrobiologie   MeSH
• Helicobacter pylori izolace a purifikace   MeSH
• infekce vyvolané Helicobacter pylori komplikace   diagnóza   epidemiologie   metabolismus   MeSH
• leukocytární L1-antigenní komplex metabolismus   MeSH
• lidé MeSH
• logistické modely MeSH
• mladiství MeSH
• prevalence MeSH
• prospektivní studie MeSH
• studie případů a kontrol MeSH
• Check Tag
• dítě MeSH
• lidé MeSH
• mladiství MeSH
• mužské pohlaví MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• pozorovací studie MeSH
• Názvy látek
• biologické markery MeSH
• leukocytární L1-antigenní komplex MeSH

Epidemiology of uninvestigated dyspepsia was studied in the Czech Republic for the first time in 2001. The aim of our current multi-centre prospective study was to evaluate dyspepsia using the same methods in a representative sample of general unselected population from the same geographical areas 10 years later. A total of 22 centres entered the study. A total of 1,836 subjects (aged 5-98 years) were enrolled. The overall prevalence of dyspepsia was 12 %; namely 3.5 % in subjects aged 5-24 years, 18 % among 25-64-year-old persons and 15 % in subjects 65 years. Despite the substantial decrease of Helicobacter pylori infection in the Czech Republic over the past 10 years, the prevalence and basic socio-demographic determinants of uninvestigated dyspepsia did not change significantly.

• MeSH
• dítě MeSH
• dospělí MeSH
• dyspepsie epidemiologie   mikrobiologie   MeSH
• Helicobacter pylori izolace a purifikace   MeSH
• infekce vyvolané Helicobacter pylori epidemiologie   MeSH
• lidé středního věku MeSH
• lidé MeSH
• mladiství MeSH
• prevalence MeSH
• prospektivní studie MeSH
• senioři nad 80 let MeSH
• senioři MeSH
• Check Tag
• dítě MeSH
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mladiství MeSH
• mužské pohlaví MeSH
• senioři nad 80 let MeSH
• senioři MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• Geografické názvy
• Česká republika epidemiologie   MeSH

To evaluate vital signs and body indices in Helicobacter pylori (H. pylori) positive and negative persons. A total of 22 centres entered the study. They were spread over the whole country, corresponding well to the geographical distribution of the Czech population. A total of 1818 subjects (aged 5-98 years) took part in the study, randomly selected out of 38147 subjects. H. pylori infection was investigated by means of a 13C-urea breath test. Data on height, weight, systolic and diastolic blood pressure and heart rate were collected at the clinics of general practitioners. The overall prevalence of H. pylori infection was 30.4% (402/1321) in adults (≥ 18 year-old) and 5.2% (26/497) in children and adolescents (≤ 17 year-old). Once adjusted for age and gender, only a difference in body mass index remained statistically significant with H. pylori positive adults showing an increase of 0.6 kg/m(2) in body mass index. Once adjusted for age and gender, we found a difference in height between H. pylori positive and H. pylori negative children and adolescents. On further adjustment for place of residence, this difference became statistically significant, with H. pylori positive children and adolescents being on average 3.5 cm shorter. H. pylori positive adults were significantly older compared to H. pylori negative subjects. Once adjusted for age and gender, H. pylori infection had no impact on body weight, body mass index and vital signs either in adults or children and adolescents. Chronic H. pylori infection appeared to be associated with short stature in children. H. pylori infection did not influence blood pressure, body weight and body mass index either in adults or children and adolescents.

• Klíčová slova
• 13C-urea breath test, Blood pressure, Body mass index, Czech Republic, Epidemiology, Heart rate, Helicobacter pylori, Stature, Weight,
• MeSH
• dechové testy MeSH
• dítě MeSH
• dospělí MeSH
• Helicobacter pylori * MeSH
• index tělesné hmotnosti MeSH
• infekce vyvolané Helicobacter pylori epidemiologie   mikrobiologie   MeSH
• krevní tlak MeSH
• lidé středního věku MeSH
• lidé MeSH
• mladiství MeSH
• mladý dospělý MeSH
• močovina chemie   MeSH
• poruchy růstu komplikace   MeSH
• předškolní dítě MeSH
• prevalence MeSH
• prospektivní studie MeSH
• senioři nad 80 let MeSH
• senioři MeSH
• srdeční frekvence MeSH
• tělesná hmotnost MeSH
• tělesná výška * MeSH
• zeměpis MeSH
• Check Tag
• dítě MeSH
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mladiství MeSH
• mladý dospělý MeSH
• mužské pohlaví MeSH
• předškolní dítě MeSH
• senioři nad 80 let MeSH
• senioři MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• multicentrická studie MeSH
• práce podpořená grantem MeSH
• Geografické názvy
• Česká republika epidemiologie   MeSH
• Názvy látek
• močovina MeSH

OBJECTIVE: Helicobacter pylori (H.p.) infections play a very important role in the development of ulcerations and malignancies of the gastrointestinal tract. It is assumed that the primary infection occurs during childhood, depending on numerous environmental factors among them hygiene and social status. Our aim was to determine whether treatment with antibiotics affects the persistence of H.p. infection. METHODS: In 2006, we conducted an epidemiological study among all grade 8 students in the city of Leipzig (mean age 14.6 years). To determine the prevalence of H.p. infection, a voluntary H.p. test (13C-urea breath test) was performed in all participants. RESULTS: The H.p. prevalence was 6.3% (N = 1,598). A significant difference was found between those students who had been treated with an antibiotic at least once prior to the test and those who had never received any antibiotics (4.0% and 11.1%, respectively, p < 0.001). H.p. prevalence decreased with increasing numbers of antibiotic treatments. CONCLUSION: In adolescence, treatment with "non-H.p. specific" antibiotics appears to significantly affect H.p. prevalence. Moreover, the actual persistence of H.p. in "chronic persistent" H.p. infections appears to fluctuate at least in younger years. Thus, any "non-H.p. specific" antibiotic treatment should be considered in the diagnosis and treatment of H.p. infections and should be taken into account as an important confounder in future epidemiological studies.

• MeSH
• antibakteriální látky aplikace a dávkování   terapeutické užití   MeSH
• dechové testy metody   MeSH
• emigranti a imigranti statistika a číselné údaje   MeSH
• Helicobacter pylori účinky léků   izolace a purifikace   MeSH
• infekce vyvolané Helicobacter pylori diagnóza   epidemiologie   MeSH
• lidé MeSH
• logistické modely MeSH
• mladiství MeSH
• močovina analýza   MeSH
• prevalence MeSH
• průzkumy a dotazníky MeSH
• socioekonomické faktory MeSH
• Check Tag
• lidé MeSH
• mladiství MeSH
• mužské pohlaví MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Geografické názvy
• Německo epidemiologie   MeSH
• Názvy látek
• antibakteriální látky MeSH
• močovina MeSH